Human embryo mosaicism: did we drop the ball on chromosomal testing?

Journal of Assisted Reproduction and Genetics

Volumn 33, Issue 11, 2016, Pages 1439-1444

  Esfandiari, Navid ^a   Bunnell, Megan E ^a   Casper, Robert F ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aneuploidy; Mosaicism; Pre implantation genetic screening; Trophectoderm biopsy

Indexed keywords

ANEUPLOIDY; BLASTOCYST; CELL POPULATION; CHROMOSOME MOSAICISM; EMBRYO; EMBRYO (ANATOMY); HUMAN; IN VITRO FERTILIZATION; INNER CELL MASS; MONOSOMY; PREIMPLANTATION GENETIC DIAGNOSIS; PRIORITY JOURNAL; REVIEW; TRIPLOIDY; TROPHECTODERM; BIOPSY; ECTODERM; EMBRYOLOGY; FEMALE; GENETIC SCREENING; GENETICS; GROWTH, DEVELOPMENT AND AGING; MOSAICISM; NIDATION; PREGNANCY;

ANEUPLOIDY; BIOPSY; ECTODERM; EMBRYO IMPLANTATION; FEMALE; FERTILIZATION IN VITRO; GENETIC TESTING; HUMANS; MOSAICISM; PREGNANCY; PREIMPLANTATION DIAGNOSIS;

EID: 84984853969     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-016-0797-y     Document Type: Review

References (37)

1. Revel A. Defective endometrial receptivity. Fertil Steril. 2012;97:1028–32.
2. Dahdouh EM, Balayla J, García-Velasco JA. Impact of blastocyst biopsy and comprehensive chromosome screening technology on preimplantation genetic screening: a systematic review of randomized controlled rrials. Reprod BioMed Online. 2015;30(3):281–9.
3. Dahdouh EM, Balayla J, Audibert F, Genetics Committee, Wilson ED, Audibert F, et al. Technical update: preimplantation genetic diagnosis and screening. J Obstet Gynaecol Can. 2015;37:451–63.
4. Brezina PR, Kutteh WH. Clinical applications of preimplantation genetic testing. BMJ. 2015;350:g7611.
5. Scott Jr RT, Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. 2013;100:624–30.
6. Sermon K, Viville S. Chromosomes in early human embryo development: incidence of chromosomal abnormalities, underlying mechanisms and consequences for development. Textbook Hum Reprod Genet. 2014;52–67.
7. Ginsburg ES, Racowsky C. Preimplanatation genetic testing: available and emerging technologies. In vitro Fertilization: Compr Guid. 2012;115–144.
8. Johnson DS, Cinnioglu C, Ross R, Filby A, Gemelos G, Hill M, Ryan A, Smotrich D
9. Novik V, Moulton EB, Sisson M, Shrestha SL, Tran K, Stern H, et al. The accuracy of chromosomal microarray testing for identification of embryonic mosaicism in human blastocysts. Mol Cytogenet. 2014;7(1):18.
10. Van Echten-Arends J, Mastenbroek S, Sikkema-Raddatz B, Korevaar JC, Heineman MJ, van der Veen F, et al. Chromosomal mosaicism in human preimplantation embryos: a systemic review. Hum Reprod Update. 2011;17:620–7.
11. Barbash-Hazan S, Frumkin T, Malcov M, Yaron Y, Cohen T, Azem F, et al. Preimplantation aneuploid embryos undergo self-correction in correlation with their developmental potential. Fertil Steril. 2009;92:890–6.
12. Barzrgar M, Gourabi H, Valojerdi MR, Yazdi PE, Beharvand H. Self-correction of chromosomal abnormalities in human preimplantation embryos and embryonic stem cells. Stem Cells Dev. 2013;22:2449–56.
13. Bolton H, Graham SJL, Niels Van Der A, Kumar P, Theunis K, Fernandez Gallardo E, et al. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential. Nat Comms. 2016;7:11165.
14. Goldberg JD, Wohlferd MM. Incidence and outcome of chromosomal mosaicism found at the time of chorionic villus sampling. Am J Obstet Gynecol. 1997;176:1349–453.
15. Haddad G, He W, Gill J, Witz C, Wang C, Kaskar K, et al. Mosaic pregnancy after transfer of a “euploid” blastocyst screened by DNA microarray. J Ovarian Res. 2013;6(1):70.
16. Kalousek DK, Dill FJ. Chromosomal mosaicism confined to the placenta in human conception. Science. 1983;221:665–7.
17. Phillips OP, Tharapel AT, Lerner JL, Park VM, Wachtel SS, Shulman LP. Risk of fetal mosaicism when placental mosaicism is diagnosed by chorionic villus sampling. Am J Obstet Gynecol. 1996;174:850–5.
18. Li M, DeUgarte CM, Surrey M, Danzer H, DeCherney H, DeCherney A, et al. Fluorescence in situ hybridization reanalysis of day-6 human blastocysts diagnosed with aneuploidy on day 3. Fertil Steril. 2005;84(5):1395–400.
19. Liu J, Wang W, Sun X, Liu L, Jin H, Li M, et al. DNA microarray reveals that high proportions of human blastocysts from women of advanced maternal age are aneuploid and mosaic. Biol Reprod. 2012;87:1–9.
20. Taylor TH, Gitlin SA, Patrick JL, Crain JL, Wilson JM, Griffin DK. The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. Hum Reprod Update. 2014;20(4):571–81.
21. Fragouli E, Alfarawati S, Spath K, Wells D. Morphological and cytogenetic assessment of cleavage and blastocyst stage embryos. Mol Hum Reprod. 2014;20:117–26.
22. Northrop LE, Treff NR, Levy B, Scott Jr RT. SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol Hum Reprod. 2010;16:590–600.
23. Evsikov S, Verlinsky Y. Mosaicism in the inner cell mass of human blastocysts. Hum Reprod. 1998;13:3151–5.
24. Delhanty JDA, Handyside AH. The origin of genetic defects in the human and their detection in the preimplantation embryo. Hum Redprod Update. 1995;1:201–15.
25. Grifo J, Colls P, Ribustello L, Escudero T, Liu E, Munné S. Why do array-CGH (aCGH) euploid embryos miscarry? Reanalysis by NGS reveals undetected abnormalities which would have prevented 56% of the miscarriages. Fertil Steril. 2015;104 Suppl 3:e14.
26. Munné S, Grifo J, Wells D. Mosaicism: “survival of the fittest” versus “no embryo left behind. Fertil Steril. 2016;Online: 1–4
27. Mamas T, Gordon A, Brown A, Harper J, Sen Gupta S. Detection of aneuploidy by array comparative genomic hybridization using cell lines to mimic a mosaic trophectoderm biopsy. Fertil Steril. 2012;97:943–7.
28. Scott Jr RT, Galiano D. The challenge of embryonic mosaicism in preimplantation genetic screening. Fertil Steril. 2016;32:337–8.
29. Esfandiari N, Bentov Y, Casper RF. Trophectoderm biopsy for aneuploidy screening using different platforms and conflicting test results. ESHRE O-034, Munich, Germany, June 29-July 2, 2014
30. Orvieto R, Shuly Y, Brengauz M, Feldman B. Should pre-implantation genetic screening be implemented to routine clinical practice? Gynecol Endocrinol. 2016;Online: 1–3.
31. Shelly KE, Johnson DS, Morrison LS, Carney SM, Boylan CF, Feinberg RF. Exploring the incidence of trophectoderm mosaicism in a population of previously diagnosed embryos. Fertil Steril. 2012;98(3):S139.
32. Capalbo A, Treff NR, Cimadomo D, Tao X, Upham K, Ubaldi FM, et al. Comparison of array comparative genomic hybridization and quantitative real time PCR-based aneuploidy screening of blastocyst biopsies. Eur J Hum Genet. 2015;23(7):901–6.
33. Wells D, Kaur K, Grifo J, Glassner M, Taylor JC, Fragouli E, et al. Clinical utilisation of a rapid Low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantation. J Med Genet. 2014;51(8):553–62.
34. Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med. 2015;373(21):2089–90.
35. Gleicher N, Vidali A, Braverman J, Kushnir VA, Albertini DF, Barad DH. Further evidence against use of PGS in poor prognosis patients: report of normal births after transfer of embryos reported as aneuploid. Fertil Steril. 2015;104(3):e59.
36. Ledbetter DH, Zachary JM, Simpson JL, Golbus MS, Pergament E, Jackson L, et al. Cytogenetic results from the US collaborative study on CVS. Prenat Diagn. 1992;12:317–45.
37. Fragouli E, Alfarawati S, Spath K, Tarozzi N, Borini A, Wells D. The developmental potential of mosaic embryos. Fertil Steril. 2015;104(3 Suppl):e96.